Henlius Biotech IPO Raises Below-Target $410m

 
• By Penelope MacRae
  
IPO
Shanghai Henlius Biotech’s IPO has raised $410m • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business